A multicenter, randomized, open-label, phase 2 study of carfilzomib with or without ARRY-520 (filanesib) in patients with advanced multiple myeloma Meeting Abstract
| Authors: | Zonder, J. A.; Raje, N. S.; Scott, E. C.; Hofmeister, C. C.; Lendvai, N.; Anderson, L. D.; Hari, P.; Orloff, G. J.; Berdeja, J. G.; Singhal, S.; Craig, M.; Valent, J. N.; Ptaszynski, M.; Schreiber, J.; Aitchison, R.; Usmani, S. Z. |
| Abstract Title: | A multicenter, randomized, open-label, phase 2 study of carfilzomib with or without ARRY-520 (filanesib) in patients with advanced multiple myeloma |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036904874 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.8612 |
| Notes: | Meeting Abstract: TPS8612 -- Source: Wos |
